These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34257050)

  • 1. COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring.
    Salabelle C; Ly Sall K; Eroukhmanoff J; Franc S; Oumbiche H; Zrafi WS; Dang Duy TL; Valentim C; Gaston F; Fernandes S; Faucherand M; Penfornis A; Amadou C
    Prim Care Diabetes; 2021 Oct; 15(5):884-886. PubMed ID: 34257050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.
    Predieri B; Leo F; Candia F; Lucaccioni L; Madeo SF; Pugliese M; Vivaccia V; Bruzzi P; Iughetti L
    Front Endocrinol (Lausanne); 2020; 11():595735. PubMed ID: 33424771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
    Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
    Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia.
    Alharthi SK; Alyusuf EY; Alguwaihes AM; Alfadda A; Al-Sofiani ME
    Diabetes Res Clin Pract; 2021 Mar; 173():108682. PubMed ID: 33539868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study.
    Di Dalmazi G; Maltoni G; Bongiorno C; Tucci L; Di Natale V; Moscatiello S; Laffi G; Pession A; Zucchini S; Pagotto U
    BMJ Open Diabetes Res Care; 2020 Oct; 8(2):. PubMed ID: 33115820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy.
    Longo M; Caruso P; Petrizzo M; Castaldo F; Sarnataro A; Gicchino M; Bellastella G; Esposito K; Maiorino MI
    Diabetes Res Clin Pract; 2020 Nov; 169():108440. PubMed ID: 32926958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in glycaemic control in paediatric and young adult type 1 diabetes patients during COVID-19 pandemic: role of telemedicine and lifestyle changes.
    Lazzeroni P; Motta M; Monaco S; Laudisio SR; Furoncoli D; Maffini V; Rubini M; Tchana B; Ruberto C; Dodi I; Iovane B
    Acta Biomed; 2021 Nov; 92(5):e2021399. PubMed ID: 34738562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Adoption of Telemedicine Along with Emergent Use of Continuous Glucose Monitors in the Ambulatory Care of Young Persons with New-Onset Type 1 Diabetes in the Time of COVID-19: A Case Series.
    Kaushal T; Ambler-Osborn L; Turcotte C; Quinn H; Laffel L
    Telemed J E Health; 2022 Jan; 28(1):107-114. PubMed ID: 33857385
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caring for a child with type 1 diabetes during COVID-19 lockdown in a developing country: Challenges and parents' perspectives on the use of telemedicine.
    Odeh R; Gharaibeh L; Daher A; Kussad S; Alassaf A
    Diabetes Res Clin Pract; 2020 Oct; 168():108393. PubMed ID: 32858098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study.
    Parise M; Tartaglione L; Cutruzzolà A; Maiorino MI; Esposito K; Pitocco D; Gnasso A; Irace C
    J Med Internet Res; 2021 Apr; 23(4):e24552. PubMed ID: 33769945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes.
    Hakonen E; Varimo T; Tuomaala AK; Miettinen PJ; Pulkkinen MA
    BMC Pediatr; 2022 Jan; 22(1):48. PubMed ID: 35045807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study.
    Wu X; Luo S; Zheng X; Ding Y; Wang S; Ling P; Yue T; Xu W; Yan J; Weng J
    J Diabetes Investig; 2021 Sep; 12(9):1708-1717. PubMed ID: 33539665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases.
    Evin F; Er E; Ata A; Jalilova A; Demir G; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):468-472. PubMed ID: 33084289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for the diabetes nurse educator to telemedically support children with type 1 diabetes on continuous glucose monitoring? The COVID-19 lockdown experience.
    Pica S; Morano C; Díez LR
    Prim Care Diabetes; 2022 Jun; 16(3):365-367. PubMed ID: 35351390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format.
    Schiller T; Zornitzki T; Ostrovsky V; Sapojnik D; Cohen L; Kunyavski T; Knobler H; Kirzhner A
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies.
    Garofolo M; Aragona M; Rodia C; Falcetta P; Bertolotto A; Campi F; Del Prato S; Penno G
    Diabetes Res Clin Pract; 2021 Oct; 180():109066. PubMed ID: 34563586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19.
    Kaushal T; Tinsley LJ; Volkening LK; Turcotte C; Laffel LM
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e4197-e4202. PubMed ID: 35948357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycaemic control in the paediatric and young adult population with type 1 diabetes following a single telehealth visit - what have we learned from the COVID-19 lockdown?
    Rachmiel M; Lebenthal Y; Mazor-Aronovitch K; Brener A; Levek N; Levran N; Chorna E; Dekel M; Barash G; Landau Z; Pinhas-Hamiel O
    Acta Diabetol; 2021 Jun; 58(6):697-705. PubMed ID: 33511493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown.
    Anjana RM; Pradeepa R; Deepa M; Jebarani S; Venkatesan U; Parvathi SJ; Balasubramanyam M; Radha V; Poongothai S; Sudha V; Shanthi Rani CS; Ranjani H; Amutha A; Manickam N; Unnikrishnan R; Mohan V
    Diabetes Technol Ther; 2020 Jul; 22(7):527-534. PubMed ID: 32522031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.